• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞癌与 AIM2:通过调控自噬和巨噬细胞极化的治疗潜力。

Hepatocellular carcinoma and AIM2: Therapeutic potential through regulation of autophagy and macrophage polarization.

机构信息

Department of liver diseases, Shandong public health clinical center, Shandong university, Jinan, Shandong, China.

出版信息

Immun Inflamm Dis. 2024 Sep;12(9):e70002. doi: 10.1002/iid3.70002.

DOI:10.1002/iid3.70002
PMID:39222064
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11367919/
Abstract

OBJECTIVE

Hepatocellular carcinoma (HCC) poses a significant challenge to global health. Its pathophysiology involves interconnected processes, including cell proliferation, autophagy, and macrophage polarization. However, the role of Absent in Melanoma 2 (AIM2) in HCC remains elusive.

METHODS

The expression of AIM2 in Huh-7 and Hep3B cell lines was manipulated and cell proliferation, autophagy, apoptosis, and migration/invasion, together with the polarization of M2 macrophages, were evaluated. The markers of autophagy pathway, LC3B, Beclin-1, and P62, underwent examination through Western blot analysis. An autophagy inhibitor, 3-MA, was used to measured the role of autophagy in HCC. Finally, the effect of AIM2 overexpression on HCC was further evaluated using a subcutaneous tumor model in nude mice.

RESULTS

Our results established that AIM2 overexpression inhibits HCC cell proliferation, migration, and invasion while promoting apoptosis and autophagy. Conversely, knockdown of AIM2 engendered opposite effects. AIM2 overexpression was correlated with reduced M2 macrophage polarization. The autophagy inhibitor substantiated AIM2's role in autophagy and identified its downstream impact on cell proliferation, migration, invasion, and macrophage polarization. In the in vivo model, overexpression of AIM2 led to the inhibition of HCC tumor growth.

CONCLUSION

The findings underscore AIM2's crucial function in modulating major biological processes in HCC, pointing to its potential as a therapeutic target. This study inaugurally demonstrated that AIM2 activates autophagy and influences macrophage polarization, playing a role in liver cancer progression.

摘要

目的

肝细胞癌(HCC)对全球健康构成重大挑战。其病理生理学涉及相互关联的过程,包括细胞增殖、自噬和巨噬细胞极化。然而,AIM2 在 HCC 中的作用仍不清楚。

方法

操纵 Huh-7 和 Hep3B 细胞系中 AIM2 的表达,评估细胞增殖、自噬、凋亡和迁移/侵袭,以及 M2 巨噬细胞的极化。通过 Western blot 分析检测自噬途径的标志物 LC3B、Beclin-1 和 P62。使用自噬抑制剂 3-MA 测量自噬在 HCC 中的作用。最后,使用裸鼠皮下肿瘤模型进一步评估 AIM2 过表达对 HCC 的影响。

结果

我们的结果表明,AIM2 过表达抑制 HCC 细胞增殖、迁移和侵袭,同时促进细胞凋亡和自噬。相反,AIM2 的敲低产生了相反的效果。AIM2 过表达与 M2 巨噬细胞极化减少相关。自噬抑制剂证实了 AIM2 在自噬中的作用,并确定了其对细胞增殖、迁移、侵袭和巨噬细胞极化的下游影响。在体内模型中,AIM2 的过表达导致 HCC 肿瘤生长受到抑制。

结论

这些发现强调了 AIM2 在调节 HCC 中主要生物学过程中的关键作用,表明其作为治疗靶点的潜力。这项研究首次表明,AIM2 激活自噬并影响巨噬细胞极化,在肝癌进展中发挥作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9568/11367919/e1c5f610b147/IID3-12-e70002-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9568/11367919/d4ddf70b73a1/IID3-12-e70002-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9568/11367919/79d07d2a4100/IID3-12-e70002-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9568/11367919/6626cd21986c/IID3-12-e70002-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9568/11367919/0d68d707f2b4/IID3-12-e70002-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9568/11367919/ea0ac24830e6/IID3-12-e70002-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9568/11367919/e1c5f610b147/IID3-12-e70002-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9568/11367919/d4ddf70b73a1/IID3-12-e70002-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9568/11367919/79d07d2a4100/IID3-12-e70002-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9568/11367919/6626cd21986c/IID3-12-e70002-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9568/11367919/0d68d707f2b4/IID3-12-e70002-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9568/11367919/ea0ac24830e6/IID3-12-e70002-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9568/11367919/e1c5f610b147/IID3-12-e70002-g001.jpg

相似文献

1
Hepatocellular carcinoma and AIM2: Therapeutic potential through regulation of autophagy and macrophage polarization.肝细胞癌与 AIM2:通过调控自噬和巨噬细胞极化的治疗潜力。
Immun Inflamm Dis. 2024 Sep;12(9):e70002. doi: 10.1002/iid3.70002.
2
Exosomal DLX6-AS1 from hepatocellular carcinoma cells induces M2 macrophage polarization to promote migration and invasion in hepatocellular carcinoma through microRNA-15a-5p/CXCL17 axis.肝癌细胞来源的外泌体 DLX6-AS1 通过微小 RNA-15a-5p/CXCL17 轴诱导 M2 型巨噬细胞极化促进肝癌迁移和侵袭
J Exp Clin Cancer Res. 2021 May 26;40(1):177. doi: 10.1186/s13046-021-01973-z.
3
HBx-mediated decrease of AIM2 contributes to hepatocellular carcinoma metastasis.HBx 介导的 AIM2 减少促进肝癌转移。
Mol Oncol. 2017 Sep;11(9):1225-1240. doi: 10.1002/1878-0261.12090. Epub 2017 Jul 11.
4
Downregulation of hsa_circ_0074854 Suppresses the Migration and Invasion in Hepatocellular Carcinoma via Interacting with HuR and via Suppressing Exosomes-Mediated Macrophage M2 Polarization.hsa_circ_0074854 的下调通过与 HuR 相互作用并抑制外泌体介导的巨噬细胞 M2 极化来抑制肝癌的迁移和侵袭。
Int J Nanomedicine. 2021 Apr 12;16:2803-2818. doi: 10.2147/IJN.S284560. eCollection 2021.
5
Loss of AIM2 expression promotes hepatocarcinoma progression through activation of mTOR-S6K1 pathway.AIM2表达缺失通过激活mTOR - S6K1信号通路促进肝癌进展。
Oncotarget. 2016 Jun 14;7(24):36185-36197. doi: 10.18632/oncotarget.9154.
6
Hypericin impedes M2 macrophage polarization and protects against Hepatocellular carcinoma.金丝桃素可阻碍M2巨噬细胞极化并预防肝细胞癌。
Mol Immunol. 2025 May;181:160-168. doi: 10.1016/j.molimm.2025.03.012. Epub 2025 Mar 27.
7
[SLC1A5 overexpression accelerates progression of hepatocellular carcinoma by promoting M2 polarization of macrophages].[SLC1A5过表达通过促进巨噬细胞的M2极化加速肝细胞癌进展]
Nan Fang Yi Ke Da Xue Xue Bao. 2025 Feb 20;45(2):269-284. doi: 10.12122/j.issn.1673-4254.2025.02.08.
8
MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.miR-424-5p 通过靶向 TRIM29 作为潜在的生物标志物抑制肝癌的增殖和侵袭。
Life Sci. 2019 May 1;224:1-11. doi: 10.1016/j.lfs.2019.03.028. Epub 2019 Mar 12.
9
LncRNA MEG3 suppresses hepatocellular carcinoma by stimulating macrophage M1 polarization and modulating immune system via inhibiting CSF-1 in vivo/vitro studies.长链非编码 RNA MEG3 通过在体内/体外研究中抑制 CSF-1 来刺激巨噬细胞 M1 极化并调节免疫系统,从而抑制肝癌。
Int J Biol Macromol. 2024 Nov;281(Pt 3):136459. doi: 10.1016/j.ijbiomac.2024.136459. Epub 2024 Oct 11.
10
LncRNA HCG11 accelerates the progression of hepatocellular carcinoma via miR-26a-5p/ATG12 axis.长链非编码 RNA HCG11 通过 miR-26a-5p/ATG12 轴加速肝细胞癌的进展。
Eur Rev Med Pharmacol Sci. 2019 Dec;23(24):10708-10720. doi: 10.26355/eurrev_201912_19771.

引用本文的文献

1
The dual roles of human PYHIN family proteins in cancer: mechanisms and therapeutic implications.人类PYHIN家族蛋白在癌症中的双重作用:机制与治疗意义
Front Immunol. 2025 May 2;16:1576674. doi: 10.3389/fimmu.2025.1576674. eCollection 2025.

本文引用的文献

1
AIM2 fosters lung adenocarcinoma immune escape by modulating PD-L1 expression in tumor-associated macrophages via JAK/STAT3.AIM2 通过调节肿瘤相关巨噬细胞中的 PD-L1 表达,经由 JAK/STAT3 促进长腺癌的免疫逃逸。
Hum Vaccin Immunother. 2023 Dec 15;19(3):2269790. doi: 10.1080/21645515.2023.2269790. Epub 2023 Oct 25.
2
Mechanism of action and treatment of type I interferon in hepatocellular carcinoma.I 型干扰素在肝细胞癌中的作用机制与治疗。
Clin Transl Oncol. 2024 Feb;26(2):326-337. doi: 10.1007/s12094-023-03266-7. Epub 2023 Jul 4.
3
New Opportunities to Individualize Frontline Therapy in Advanced Stages of Hepatocellular Carcinoma.
肝细胞癌晚期个体化一线治疗的新机遇。
Drugs. 2023 Aug;83(12):1091-1109. doi: 10.1007/s40265-023-01907-3. Epub 2023 Jul 4.
4
The burden and trend of liver metastases in Shanghai, China: a population-based study.中国上海的肝转移瘤负担和趋势:一项基于人群的研究。
Eur J Cancer Prev. 2023 Nov 1;32(6):517-524. doi: 10.1097/CEJ.0000000000000823. Epub 2023 Jul 3.
5
Indolent cancer and pattern of progression: Two missing parameters in trial design for hepatology.惰性癌症和进展模式:肝病临床试验设计中的两个缺失参数。
Hepatology. 2024 Jun 1;79(6):1452-1462. doi: 10.1097/HEP.0000000000000527. Epub 2023 Jul 3.
6
Intratumoral PPT1-positive macrophages determine immunosuppressive contexture and immunotherapy response in hepatocellular carcinoma.肿瘤内 PPT1 阳性巨噬细胞决定肝癌的免疫抑制微环境和免疫治疗反应。
J Immunother Cancer. 2023 Jun;11(6). doi: 10.1136/jitc-2022-006655.
7
Yangqing Chenfei formula alleviates silica-induced pulmonary inflammation in rats by inhibiting macrophage M1 polarization.养清尘肺方通过抑制巨噬细胞M1极化减轻大鼠矽肺诱导的肺部炎症。
Chin Med. 2023 Jun 28;18(1):79. doi: 10.1186/s13020-023-00787-9.
8
Aquaporin 1 Facilitates Ferroptosis, M1 Polarization, Mitochondrial Dysfunction, and Autophagy Damage on Lipopolysaccharide-Induced Macrophage Through Down-Regulation of P53 Signaling Pathway.水通道蛋白 1 通过下调 P53 信号通路促进脂多糖诱导的巨噬细胞铁死亡、M1 极化、线粒体功能障碍和自噬损伤。
DNA Cell Biol. 2023 Aug;42(8):456-480. doi: 10.1089/dna.2023.0016. Epub 2023 Jun 28.
9
Non-Alcoholic Fatty Liver Disease: Translating Disease Mechanisms into Therapeutics Using Animal Models.非酒精性脂肪性肝病:利用动物模型将疾病机制转化为治疗方法。
Int J Mol Sci. 2023 Jun 10;24(12):9996. doi: 10.3390/ijms24129996.
10
The Efficacy and Safety of Ramucirumab in Heavily Pretreated Advanced Hepatocellular Carcinoma.雷莫芦单抗治疗广泛预处理的晚期肝细胞癌的疗效和安全性。
Anticancer Res. 2023 Jul;43(7):3203-3212. doi: 10.21873/anticanres.16494.